On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy

  • Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy
  • CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life
  • Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products

Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://ibn.fm/TDwpd). As scientific evidence supporting the use of CBD becomes mainstream, concerns about absorbability, shelf life and bioavailability continue to mount. CannAssist International (OTCQB: CNSC) is dedicated to addressing these problems through the creation of CBD products using their branded technology CiBiDinol specifically created to overcome these critical issues.  Marketed under the Xceptol consumer brand, CNSC’s line of products promise increased efficacy, absorption and bioavailability for superior results and efficiency per dose.

Treating epilepsy using CBD is not a new phenomenon. One of the best-known cases dates back to 2012 and concerns Charlotte Figi, a little girl who suffered up to 300 grand mal seizures per week that kept her confined to a wheelchair. The use of CBD oil to treat her condition reduced the number of seizures to 2-3 per month and sparked the medical marijuana movement that catalyzed the lifting of prohibitions on cannabis-based products throughout the United States (https://ibn.fm/dy5YL). The Imperial College of London review mirrors those results through a study that reported a 97% reduction in the monthly frequency of seizures when patients received whole-plant extract cannabis treatment.

“Patients and their families deserve better, so we implore policy makers, regulators and public health bodies to prioritize the health of these individuals and help them to access in the NHS medicines which are making a dramatic improvement to their lives,” said Rayyan Zafar, a Ph.D. candidate in the Department of Brain Sciences at the Imperial College of London (https://ibn.fm/NIb3h).

Quality is a primary concern among consumers of CBD, particularly as it enters the mainstream to include new users across a wide range of demographics. CNSC uses a quality-focused proprietary process where CBD molecules are combined with penetration-enhancing cyclodextrin in order to modify the surface of the molecule and render it water dispersible. Besides enhanced potency, Xceptol products were found via third-party testing to have a 400% increase in skin penetration along with a 300% increase in the rate of gut absorption when compared to regular oil-based CBD (https://ibn.fm/PgOMt).

Established in May 2017, CannAssist is headquartered in San Diego, California. The company’s Xceptol products are also sold online through the Range Me product marketplace and multiple international sales channels that include Central America, South America, South Africa, the EU, the UK and the Philippines.

For more information, visit the company’s website at www.CannAssistInternational.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC 

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
[email protected]

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Archives

Select A Month
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered